Sign in
Stories
Biotechnology and Skin Cancer Detection Markets
Share
Allergy Diagnostics Market: Rising Preva...
Booming Markets: Mask Fit Test, Dispensi...
Disposable Face Masks and Facial Tissues...
Asia Pacific Melamine Formaldehyde Marke...
Asia Pacific Poised for Diagnostics Grow...
Aspira Women’s Health Secures Distributi...
Overview
API
The global antibody production market is set to exceed USD 30.7 billion by 2031, driven by factors such as the increasing use of antibodies in therapeutic drugs, the rise in chronic diseases, and the emphasis on personalized medicines. Technological advancements in biotechnology are also contributing to the market's growth. On the other hand, the skin cancer detection devices market is expected to reach US$ 2.95 billion by 2033, fueled by growing awareness, technological advancements, and rising demand for early and accurate diagnosis. Major companies are investing in R&D efforts and forming strategic alliances to meet the growing market needs.
Ask a question
How might the growth of the antibody production market impact the pharmaceutical industry and patient care?
In what ways can the growth of the antibody production and skin cancer detection markets influence the future of healthcare and healthcare technology?
What are the potential implications of technological advancements in skin cancer detection devices on patient diagnosis and treatment?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
May 2023
Jun 2023
Coverage